Notable Thursday Option Activity: JBL, NTLA, TMDX

Intellia Therapeutics (NTLA) and TransMedics Group (TMDX) are experiencing notably high options trading activity today, with NTLA's options volume representing 52% of its average daily share volume and TMDX's at 51.9%. Specifically, the $15 strike call option expiring October 2025 for NTLA and the $110 strike put option expiring September 2025 for TMDX are seeing significant volume, indicating concentrated directional interest or hedging strategies by market participants.

Analysis

Intellia Therapeutics (NTLA) and TransMedics Group (TMDX) are experiencing unusually high options market activity, indicating significant strategic positioning by investors. For NTLA, today's options volume of 22,322 contracts equates to 52% of its 30-day average daily share volume of 4.3 million. The activity is heavily concentrated in the October 2025 $15 strike call options, which have traded 4,625 contracts. This specific, long-dated bullish positioning suggests that certain market participants are speculating on or hedging for a substantial increase in the stock's value over the next year. Similarly, TMDX has seen options volume reach 51.9% of its average daily share volume, with 5,099 contracts traded. The focus here is on the September 2025 $110 strike put options, with 1,879 contracts changing hands. This indicates a notable bearish bet or a significant hedging operation against a long position in TMDX, pointing to perceived downside risk on a long-term horizon. The concentration in specific long-dated strikes for both stocks implies these are not random retail trades but more likely deliberate, large-scale institutional maneuvers.

Key Decisions for Investors

• The concentrated volume in long-dated NTLA call options at the $15 strike signals a strong bullish sentiment from certain market participants, prompting a closer look at the company's long-term pipeline and potential catalysts.